COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1212: Articles 12111-12120  | Next

The effects of communicating uncertainty around statistics on public trust: an international study
Kerr, J. R., van der Bles, A. M., Schneider, C., Dryhurst, S., Chopurian, V., Freeman, A. L., van der Linden, S.
10.1101/2021.09.27.21264202 — Posted: 2021-09-29
Prevalence of SARS-CoV-2: An age-stratified, population-based, seroepidemiological survey in Islamabad, Pakistan
Baig, M. A., Ansari, J. A., Ikram, A., Khan, M. A., Salman, M., Hussain, Z., Baig, M. Z. I., Chaudhry, A., Malik, M. W., Akram, K. S., Saeed, A., Ranjha, M. A., Sultan, F., Sabir, S.
10.1101/2021.09.27.21264003 — Posted: 2021-09-29 Discussion: Onsite
Persistence of neuropsychiatric symptoms associated with SARS-CoV-2 positivity among a cohort of children and adolescents
Castro, V. M., Gunning, F. M., Perlis, R. H.
10.1101/2021.09.28.21264259 — Posted: 2021-09-29
How well does SARS-CoV-2 spread in hospitals?
Shirreff, G., Zahar, J.-R., Cauchemez, S., Temime, L., Opatowski, L.
10.1101/2021.09.28.21264066 — Posted: 2021-09-29
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant
Acharya, C. B., Schrom, J., Mitchell, A. M., Coil, D. A., Marquez, C., Rojas, S., Wang, C. Y., Liu, J., Pilarowski, G., Solis, L., Georgian, E., Petersen, M., DeRisi, J., Michelmore, R., Havlir, D.
10.1101/2021.09.28.21264262 — Posted: 2021-09-29 Discussion: Onsite
A PTX3/LDH/CRP signature correlates with lung injury CTs scan severity and disease progression in paucisymptomatic COVID-19
Folci, M., Brunetta, E., Lanza, E., Bottazzi, B., Protti, A., Messana, G., Lisi, C., Leone, R., Sironi, M., Generali, E., Rodolfi, S., Sagasta, M., Voza, A., Ciccarelli, M., Garlanda, C., Balzarini, L., Mantovani, A., Cecconi, M., Humanitas COVID-19 Task Force
10.1101/2021.09.29.21264061 — Posted: 2021-09-29
The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission
Eyre, D. W., Taylor, D., Purver, M., Chapman, D., Fowler, T., Pouwels, K., Walker, A. S., Peto, T. E.
10.1101/2021.09.28.21264260 — Posted: 2021-09-29 Discussion: Onsite
CovRNN - A recurrent neural network model for predicting outcomes of COVID-19 patients: model development and validation using EHR data
Rasmy, L., Nigo, M., Kannadath, B. S., Xie, Z., Mao, B., Patel, K., Zhou, Y., Zhang, W., Ross, A. M., Xu, H., Zhi, D.
10.1101/2021.09.27.21264121 — Posted: 2021-09-29
Young adults vulnerability to COVID-19 in Brazil: an overview across the country
Souza, F. S. H., Hojo-Souza, N. S., de Oliveira, D. C. R., da Silva, C. M., Guidoni, D. L.
10.1101/2021.09.27.21264086 — Posted: 2021-09-29
Calibrating an SIR model for South Korea COVID-19 infections and predicting vaccination impact
Pae, B.
10.1101/2021.09.27.21264172 — Posted: 2021-09-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).